关注
Aishwarya Gondane
Aishwarya Gondane
在 helsinki.fi 的电子邮件经过验证
标题
引用次数
引用次数
年份
Revealing the history and mystery of RNA-Seq
A Gondane, HM Itkonen
Current Issues in Molecular Biology 45 (3), 1860-1874, 2023
182023
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.
IHM Hu Q, Poulose N, Girmay S, Helevä A, Doultsinos D, Gondane A, Steele RE ...
RNA Biology, 2021
182021
Spatially conserved motifs in complement control protein domains determine functionality in regulators of complement activation-family proteins
H Ojha, P Ghosh, H Singh Panwar, R Shende, A Gondane, SC Mande, ...
Communications Biology 2 (1), 290, 2019
162019
O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition
A Gondane, N Poulose, S Walker, IG Mills, HM Itkonen
Glycobiology 32 (9), 751-759, 2022
92022
Castration-resistant prostate cancer cells are dependent on the high activity of CDK7
S Pallasaho, A Gondane, A Kuivalainen, S Girmay, S Moestue, M Loda, ...
Journal of Cancer Research and Clinical Oncology 149 (8), 5255-5263, 2023
52023
Compromised CDK12 activity causes dependency on the non-essential spliceosome components
S Pallasaho, A Gondane, D Duveau, C Thomas, M Loda, HM Itkonen
bioRxiv, 2021.12. 07.470703, 2021
22021
CDK12‐inactivation‐induced MYC signaling causes dependency on the splicing kinase SRPK1
J Liang, A Gondane, HM Itkonen
Molecular oncology, 2024
12024
CDK9 inhibition activates innate immune response through viral mimicry
S Yalala, A Gondane, N Poulose, J Liang, IG Mills, HM Itkonen
FASEB Journal 38 (8), e23628, 2024
12024
CDK9 inhibition activates innate immune response in prostate cancer cells
S Yalala, A Gondane, N Poulose, J Liang, IG Mills, HM Itkonen
Cancer Research 84 (6_Supplement), 528-528, 2024
2024
O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage
IHM Gondane A, Girmay S, Helevä A, Pallasaho S, Loda M
2022
系统目前无法执行此操作,请稍后再试。
文章 1–10